Mind the lipids: hyperlipidaemia resultant from JAK inhibitor use in inflammatory bowel disease. Ng A. Eur J Gastroenterol Hepatol 2021;33.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ng A. Mind the lipids: hyperlipidaemia resultant from JAK inhibitor use in inflammatory bowel disease. Eur J Gastroenterol Hepatol 2021;33.
PMID: 35048673